- Home
- IMVT vs SGHC Comparison
IMVT vs SGHC Comparison
Compare IMVT & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- SGHC
- Stock Information
- Founded
- IMVT N/A
- SGHC 2020
- Country
- IMVT United States
- SGHC Guernsey
- Employees
- IMVT N/A
- SGHC N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- SGHC Services-Misc. Amusement & Recreation
- Sector
- IMVT Health Care
- SGHC Consumer Discretionary
- Exchange
- IMVT Nasdaq
- SGHC Nasdaq
- Market Cap
- IMVT 3.4B
- SGHC 3.6B
- IPO Year
- IMVT N/A
- SGHC N/A
- Fundamental
- Price
- IMVT $18.37
- SGHC $6.62
- Analyst Decision
- IMVT Strong Buy
- SGHC Strong Buy
- Analyst Count
- IMVT 11
- SGHC 5
- Target Price
- IMVT $44.13
- SGHC $10.40
- AVG Volume (30 Days)
- IMVT 1.9M
- SGHC 863.7K
- Earning Date
- IMVT 02-06-2025
- SGHC 05-07-2025
- Dividend Yield
- IMVT N/A
- SGHC 4.38%
- EPS Growth
- IMVT N/A
- SGHC N/A
- EPS
- IMVT N/A
- SGHC 0.01
- Revenue
- IMVT N/A
- SGHC $1,736,303,814.00
- Revenue This Year
- IMVT $108.88
- SGHC $18.72
- Revenue Next Year
- IMVT N/A
- SGHC $11.20
- P/E Ratio
- IMVT N/A
- SGHC $733.94
- Revenue Growth
- IMVT N/A
- SGHC 10.78
- 52 Week Low
- IMVT $17.01
- SGHC $2.90
- 52 Week High
- IMVT $34.47
- SGHC $8.51
- Technical
- Relative Strength Index (RSI)
- IMVT 42.05
- SGHC 39.71
- Support Level
- IMVT $17.49
- SGHC $6.75
- Resistance Level
- IMVT $18.96
- SGHC $7.11
- Average True Range (ATR)
- IMVT 1.23
- SGHC 0.26
- MACD
- IMVT -0.01
- SGHC 0.00
- Stochastic Oscillator
- IMVT 39.65
- SGHC 28.26
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates global online sports betting and gaming businesses. The company has two reportable segments, namely Betway and Spin. The majority of the company's revenue comes from the Betway segment, which is a single-brand online sportsbook business with a global reach. Betway has formed strategic partnerships with teams and leagues across the world and recovers sponsorship marketing spend through brand license agreements. The Betway segment generates the majority of the company's revenue.